Those patents were directed to chemically modified guide RNAs (“gRNA”) and their use in the CRISPR-Cas system, which permits selectively cleaving DNA at particular target sites.

CRISPR Therapeutics: 2025 TIME100 Most Influential CompaniesCRISPR Therapeutics is a biotech company that borrows its name from the groundbreaking gene editing technology CRISPR. As of last year ...

CRISPR/Cas-based diagnostics are poised to transform precision oncology by enabling faster, cheaper, and more accurate tumor biomarker detection—from genes to proteins to liquid biopsies.

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for CRISPR-powered biomedicine.

Discover how CRISPR-Cas9 technology is revolutionizing spider silk production with red fluorescent fibers and advancing genetic research.

KJ Muldoon became the first patient to undergo personalized CRISPR treatment, a therapy that found the one uniquely mutated gene out of 20,000 in his little body, and fixed it.

Biotech Appeals court reignites CRISPR discovery row, raising questions about gene editing biotech patents By Nick Paul Taylor May 13, 2025 8:00am ...

The CRISPR patents are back in play. Yesterday, the US Court of Appeals for the Federal Circuit said scientists Jennifer Doudna and Emmanuelle Charpentier will get another chance to show they ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...

CRISPR Tx reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310.